GAA Gene Glycogen Storage Disease Type 2 Genetic Test
At DNA Labs UAE, we offer the GAA Gene Glycogen Storage Disease Type 2 Genetic Test. This genetic test analyzes the GAA gene for mutations associated with glycogen storage disease type 2 (GSD2), also known as Pompe disease.
Test Details
GSD2 is a rare genetic disorder characterized by the buildup of glycogen in various tissues, particularly in muscles and the liver. Our GAA gene glycogen storage disease type 2 NGS genetic test uses next-generation sequencing (NGS) technology to examine the entire coding region of the GAA gene, which encodes the enzyme acid alpha-glucosidase.
Mutations in the GAA gene can result in a deficiency or dysfunction of the enzyme, leading to the accumulation of glycogen. Our NGS genetic testing allows for a comprehensive analysis of the GAA gene, identifying various types of mutations, including point mutations, insertions, deletions, and duplications.
This enables us to provide an accurate diagnosis and identification of disease-causing mutations in individuals suspected of having GSD2. Our test can be useful for confirming a diagnosis, predicting the severity of the disease, providing information on disease progression, and guiding treatment decisions.
Additionally, our GAA gene glycogen storage disease type 2 NGS genetic test can be used for carrier testing in individuals with a family history of GSD2 or for prenatal testing in couples at risk of having an affected child.
It is important to note that genetic testing should be performed and interpreted by healthcare professionals with expertise in genetics. We recommend genetic counseling to discuss the implications and potential outcomes of the test results.
Test Components and Price
- Test Name: GAA Gene Glycogen Storage Disease Type 2 Genetic Test
- Components: GAA gene analysis
- Price: 4400.0 AED
Sample Condition
We accept the following sample conditions:
- Blood
- Extracted DNA
- One drop of blood on FTA Card
Report Delivery
Our report delivery time is typically 3 to 4 weeks from the date of sample collection.
Method
We utilize NGS technology for our GAA Gene Glycogen Storage Disease Type 2 Genetic Test.
Test Type
Our GAA Gene Glycogen Storage Disease Type 2 Genetic Test falls under the category of Metabolic Disorders.
Doctor
Our test can be ordered by a General Physician.
Test Department
Our GAA Gene Glycogen Storage Disease Type 2 Genetic Test is conducted in our Genetics department.
Pre Test Information
Prior to undergoing the GAA Gene Glycogen Storage Disease Type 2 NGS Genetic DNA Test, we recommend providing a clinical history of the patient. Additionally, a Genetic Counselling session may be conducted to draw a pedigree chart of family members affected with Glycogen Storage Disease Type 2.
For more information or to schedule an appointment for the GAA Gene Glycogen Storage Disease Type 2 Genetic Test, please contact DNA Labs UAE.
Test Name | GAA Gene Glycogen storage disease type 2 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for GAA Gene Glycogen storage disease type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glycogen storage disease type 2 |
Test Details |
GAA gene glycogen storage disease type 2 NGS genetic test is a genetic test that analyzes the GAA gene for mutations associated with glycogen storage disease type 2 (GSD2), also known as Pompe disease. GSD2 is a rare genetic disorder characterized by the buildup of glycogen in various tissues, particularly in muscles and the liver. The test uses next-generation sequencing (NGS) technology to examine the entire coding region of the GAA gene, which encodes the enzyme acid alpha-glucosidase. Mutations in this gene result in a deficiency or dysfunction of the enzyme, leading to the accumulation of glycogen. NGS genetic testing allows for a comprehensive analysis of the GAA gene, identifying various types of mutations, including point mutations, insertions, deletions, and duplications. This enables accurate diagnosis and identification of disease-causing mutations in individuals suspected of having GSD2. The test can be useful for confirming a diagnosis, predicting the severity of the disease, providing information on disease progression, and guiding treatment decisions. It can also be used for carrier testing in individuals with a family history of GSD2 or for prenatal testing in couples at risk of having an affected child. It is important to note that genetic testing should be performed and interpreted by healthcare professionals with expertise in genetics, and genetic counseling is recommended to discuss the implications and potential outcomes of the test results. |